Related Experiment Video
Updated: May 12, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
The complement regulator CD46 is bactericidal to Helicobacter pylori and blocks urease activity
Rahma Basmarke-Wehelie1, Hong Sjölinder, Wiktor Jurkowski
1Department of Genetics, Microbiology and Toxicology, Stockholm University, Stockholm, Sweden.
The complement regulator CD46 acts as an antimicrobial agent against Helicobacter pylori. CD46 peptides show potential for eradicating H. pylori infections, offering a new therapeutic approach.
Area of Science:
- Immunology
- Microbiology
- Gastroenterology
Background:
- CD46 is a complement regulator and pathogen receptor.
- Helicobacter pylori causes gastric diseases.
- The interaction between CD46 and H. pylori was investigated.
Purpose of the Study:
- To examine the interaction between CD46 and H. pylori.
- To determine if CD46 can inhibit H. pylori growth and pathogenicity.
Main Methods:
- Gastric epithelial cells and H. pylori strains were used.
- Flow cytometry, microscopy, and ELISAs evaluated bacterial interaction with CD46.
- Bacterial survival assays and in vivo studies were performed.
Main Results:
- H. pylori infection led to CD46 shedding.
- Soluble CD46 inhibited H. pylori growth by targeting urease and alkyl hydroperoxide reductase.
- CD46 peptides blocked bacterial urease activity and acid survival.
- Oral CD46 peptide treatment eradicated H. pylori in mice.
Conclusions:
- CD46 demonstrates antimicrobial properties against H. pylori.
- CD46 peptides represent a potential therapeutic strategy for H. pylori infections.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology